APO RESEARCH · REPORT
Glucosamine
Glucosamine is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids. Glucosamine is part of the structure of the polysaccharides, chitosan, and chitin. Glucosamine is one of the most abundant monosaccharides. Produced commercially by the hydrolysis of shellfish exoskeletons or, less commonly, by fermentation of a grain such as corn or wheat, glucosamine has many names depending on country.
Product & engineering
Understand the product.
Glucosamine is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids. Glucosamine is part of the structure of the polysaccharides, chitosan, and chitin. Glucosamine is one of the most abundant monosaccharides. Produced commercially by the hydrolysis of shellfish exoskeletons or, less commonly, by fermentation of a grain such as corn or wheat, glucosamine has many names depending on country.
Selected research
Market Outlook & Growth Opportunities
Global Glucosamine Market Outlook and Growth Opportunities 2026
Market perspective
Glucosamine is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids. Glucosamine is part of the structure of the polysaccharides, chitosan, and chitin. Glucosamine is one of the most abundant monosaccharides. Produced commercially by the hydrolysis of shellfish exoskeletons or, less commonly, by fermentation of a grain such as corn or wheat, glucosamine has many names depending on country.
CELLMARK, Cargill, Koyo Chemical, Wellable Marine Biotech, Zhejiang Aoxing and so on are the major players of glucosamine for the time being.
China is the largest manufacturer of glucosamine currently. Meanwhile, North American and European regions are the major consumers.
Read the full market overview
This report provides an overview of the global Glucosamine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Glucosamine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Glucosamine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glucosamine market size, projected growth trends, production technologies, key applications, and end-use industries.
Glucosamine Segment by Company
KOYO Chemical
Cargill
YSK
Bayir Chemicals
Panvo Organics
TSI
Wellable Marine Biotech
Golden-Shell Pharmaceutical
Aoxing Biotechnology
Yangzhou Rixing Bio-Tech
Fengrun Biochemical
Dongcheng Biochemical
Chengyi Pharmaceutical
Nanjing Health Herb Bio-Tech
Shinfuda Marine Biotechnology
Glucosamine Segment by Type
Glucosamine Hydrochloride
Glucosamine Sulfate Potassium Chloride
Glucosamine Sulfate Sodium Chloride
N-Acetylglucosamine
Glucosamine Segment by Application
Health Food
Medicine
Cosmetics
Glucosamine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Glucosamine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Glucosamine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Glucosamine significant trends, drivers, influence factors in global and regions.
6. To analyze Glucosamine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucosamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glucosamine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucosamine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Glucosamine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Glucosamine industry.
Chapter 3: Detailed analysis of Glucosamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Glucosamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Glucosamine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Glucosamine Hydrochloride
- Glucosamine Sulfate Potassium Chloride
- Glucosamine Sulfate Sodium Chloride
- N-Acetylglucosamine
Applications
- Health Food
- Medicine
- Cosmetics
Companies covered
- KOYO Chemical
- Cargill
- YSK
- Bayir Chemicals
- Panvo Organics
- TSI
- Wellable Marine Biotech
- Golden-Shell Pharmaceutical
- Aoxing Biotechnology
- Yangzhou Rixing Bio-Tech
- Fengrun Biochemical
- Dongcheng Biochemical
- Chengyi Pharmaceutical
- Nanjing Health Herb Bio-Tech
- Shinfuda Marine Biotechnology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Glucosamine Sales Value (2021-2032)
- 1.2.2 Global Glucosamine Sales Volume (2021-2032)
- 1.2.3 Global Glucosamine Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Glucosamine Market Dynamics
- 2.1 Glucosamine Industry Trends
- 2.2 Glucosamine Industry Drivers
- 2.3 Glucosamine Industry Opportunities and Challenges
- 2.4 Glucosamine Industry Restraints
3 Glucosamine Market by Company
- 3.1 Global Glucosamine Company Revenue Ranking in 2025
- 3.2 Global Glucosamine Revenue by Company (2021-2026)
- 3.3 Global Glucosamine Sales Volume by Company (2021-2026)
- 3.4 Global Glucosamine Average Price by Company (2021-2026)
- 3.5 Global Glucosamine Company Ranking (2024-2026)
- 3.6 Global Glucosamine Company Manufacturing Base and Headquarters
- 3.7 Global Glucosamine Company Product Type and Application
- 3.8 Global Glucosamine Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Glucosamine Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Glucosamine Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Glucosamine Market by Type
- 4.1 Glucosamine Type Introduction
- 4.1.1 Glucosamine Hydrochloride
- 4.1.2 Glucosamine Sulfate Potassium Chloride
- 4.1.3 Glucosamine Sulfate Sodium Chloride
- 4.1.4 N-Acetylglucosamine
- 4.2 Global Glucosamine Sales Volume by Type
- 4.2.1 Global Glucosamine Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Glucosamine Sales Volume by Type (2021-2032)
- 4.2.3 Global Glucosamine Sales Volume Share by Type (2021-2032)
- 4.3 Global Glucosamine Sales Value by Type
- 4.3.1 Global Glucosamine Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Glucosamine Sales Value by Type (2021-2032)
- 4.3.3 Global Glucosamine Sales Value Share by Type (2021-2032)
5 Glucosamine Market by Application
- 5.1 Glucosamine Application Introduction
- 5.1.1 Health Food
- 5.1.2 Medicine
- 5.1.3 Cosmetics
- 5.2 Global Glucosamine Sales Volume by Application
- 5.2.1 Global Glucosamine Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Glucosamine Sales Volume by Application (2021-2032)
- 5.2.3 Global Glucosamine Sales Volume Share by Application (2021-2032)
- 5.3 Global Glucosamine Sales Value by Application
- 5.3.1 Global Glucosamine Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Glucosamine Sales Value by Application (2021-2032)
- 5.3.3 Global Glucosamine Sales Value Share by Application (2021-2032)
6 Glucosamine Regional Sales and Value Analysis
- 6.1 Global Glucosamine Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Glucosamine Sales by Region (2021-2032)
- 6.2.1 Global Glucosamine Sales by Region: 2021-2026
- 6.2.2 Global Glucosamine Sales by Region (2027-2032)
- 6.3 Global Glucosamine Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Glucosamine Sales Value by Region (2021-2032)
- 6.4.1 Global Glucosamine Sales Value by Region: 2021-2026
- 6.4.2 Global Glucosamine Sales Value by Region (2027-2032)
- 6.5 Global Glucosamine Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Glucosamine Sales Value (2021-2032)
- 6.6.2 North America Glucosamine Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Glucosamine Sales Value (2021-2032)
- 6.7.2 Europe Glucosamine Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Glucosamine Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Glucosamine Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Glucosamine Sales Value (2021-2032)
- 6.9.2 South America Glucosamine Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Glucosamine Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Glucosamine Sales Value Share by Country, 2025 VS 2032
7 Glucosamine Country-level Sales and Value Analysis
- 7.1 Global Glucosamine Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Glucosamine Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Glucosamine Sales by Country (2021-2032)
- 7.3.1 Global Glucosamine Sales by Country (2021-2026)
- 7.3.2 Global Glucosamine Sales by Country (2027-2032)
- 7.4 Global Glucosamine Sales Value by Country (2021-2032)
- 7.4.1 Global Glucosamine Sales Value by Country (2021-2026)
- 7.4.2 Global Glucosamine Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Glucosamine Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Glucosamine Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Glucosamine Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Glucosamine Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Glucosamine Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Glucosamine Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Glucosamine Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Glucosamine Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Glucosamine Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Glucosamine Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Glucosamine Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Glucosamine Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Glucosamine Sales Value Growth Rate (2021-2032)
- 7.9.2 France Glucosamine Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Glucosamine Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Glucosamine Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Glucosamine Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Glucosamine Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Glucosamine Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Glucosamine Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Glucosamine Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Glucosamine Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Glucosamine Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Glucosamine Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Glucosamine Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Glucosamine Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Glucosamine Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Glucosamine Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Glucosamine Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Glucosamine Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Glucosamine Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Glucosamine Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Glucosamine Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Glucosamine Sales Value Growth Rate (2021-2032)
- 7.16.2 China Glucosamine Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Glucosamine Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Glucosamine Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Glucosamine Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Glucosamine Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Glucosamine Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Glucosamine Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Glucosamine Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Glucosamine Sales Value Growth Rate (2021-2032)
- 7.19.2 India Glucosamine Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Glucosamine Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Glucosamine Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Glucosamine Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Glucosamine Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Glucosamine Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Glucosamine Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Glucosamine Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Glucosamine Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Glucosamine Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Glucosamine Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Glucosamine Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Glucosamine Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Glucosamine Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Glucosamine Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Glucosamine Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Glucosamine Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Glucosamine Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Glucosamine Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Glucosamine Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Glucosamine Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Glucosamine Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Glucosamine Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Glucosamine Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Glucosamine Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Glucosamine Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Glucosamine Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Glucosamine Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Glucosamine Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Glucosamine Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Glucosamine Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Glucosamine Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Glucosamine Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Glucosamine Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Glucosamine Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Glucosamine Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Glucosamine Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Glucosamine Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Glucosamine Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Glucosamine Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Glucosamine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 KOYO Chemical
- 8.1.1 KOYO Chemical Company Information
- 8.1.2 KOYO Chemical Business Overview
- 8.1.3 KOYO Chemical Glucosamine Sales, Value and Gross Margin (2021-2026)
- 8.1.4 KOYO Chemical Glucosamine Product Portfolio
- 8.1.5 KOYO Chemical Recent Developments
- 8.2 Cargill
- 8.2.1 Cargill Company Information
- 8.2.2 Cargill Business Overview
- 8.2.3 Cargill Glucosamine Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Cargill Glucosamine Product Portfolio
- 8.2.5 Cargill Recent Developments
- 8.3 YSK
- 8.3.1 YSK Company Information
- 8.3.2 YSK Business Overview
- 8.3.3 YSK Glucosamine Sales, Value and Gross Margin (2021-2026)
- 8.3.4 YSK Glucosamine Product Portfolio
- 8.3.5 YSK Recent Developments
- 8.4 Bayir Chemicals
- 8.4.1 Bayir Chemicals Company Information
- 8.4.2 Bayir Chemicals Business Overview
- 8.4.3 Bayir Chemicals Glucosamine Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Bayir Chemicals Glucosamine Product Portfolio
- 8.4.5 Bayir Chemicals Recent Developments
- 8.5 Panvo Organics
- 8.5.1 Panvo Organics Company Information
- 8.5.2 Panvo Organics Business Overview
- 8.5.3 Panvo Organics Glucosamine Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Panvo Organics Glucosamine Product Portfolio
- 8.5.5 Panvo Organics Recent Developments
- 8.6 TSI
- 8.6.1 TSI Company Information
- 8.6.2 TSI Business Overview
- 8.6.3 TSI Glucosamine Sales, Value and Gross Margin (2021-2026)
- 8.6.4 TSI Glucosamine Product Portfolio
- 8.6.5 TSI Recent Developments
- 8.7 Wellable Marine Biotech
- 8.7.1 Wellable Marine Biotech Company Information
- 8.7.2 Wellable Marine Biotech Business Overview
- 8.7.3 Wellable Marine Biotech Glucosamine Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Wellable Marine Biotech Glucosamine Product Portfolio
- 8.7.5 Wellable Marine Biotech Recent Developments
- 8.8 Golden-Shell Pharmaceutical
- 8.8.1 Golden-Shell Pharmaceutical Company Information
- 8.8.2 Golden-Shell Pharmaceutical Business Overview
- 8.8.3 Golden-Shell Pharmaceutical Glucosamine Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Golden-Shell Pharmaceutical Glucosamine Product Portfolio
- 8.8.5 Golden-Shell Pharmaceutical Recent Developments
- 8.9 Aoxing Biotechnology
- 8.9.1 Aoxing Biotechnology Company Information
- 8.9.2 Aoxing Biotechnology Business Overview
- 8.9.3 Aoxing Biotechnology Glucosamine Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Aoxing Biotechnology Glucosamine Product Portfolio
- 8.9.5 Aoxing Biotechnology Recent Developments
- 8.10 Yangzhou Rixing Bio-Tech
- 8.10.1 Yangzhou Rixing Bio-Tech Company Information
- 8.10.2 Yangzhou Rixing Bio-Tech Business Overview
- 8.10.3 Yangzhou Rixing Bio-Tech Glucosamine Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Yangzhou Rixing Bio-Tech Glucosamine Product Portfolio
- 8.10.5 Yangzhou Rixing Bio-Tech Recent Developments
- 8.11 Fengrun Biochemical
- 8.11.1 Fengrun Biochemical Company Information
- 8.11.2 Fengrun Biochemical Business Overview
- 8.11.3 Fengrun Biochemical Glucosamine Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Fengrun Biochemical Glucosamine Product Portfolio
- 8.11.5 Fengrun Biochemical Recent Developments
- 8.12 Dongcheng Biochemical
- 8.12.1 Dongcheng Biochemical Company Information
- 8.12.2 Dongcheng Biochemical Business Overview
- 8.12.3 Dongcheng Biochemical Glucosamine Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Dongcheng Biochemical Glucosamine Product Portfolio
- 8.12.5 Dongcheng Biochemical Recent Developments
- 8.13 Chengyi Pharmaceutical
- 8.13.1 Chengyi Pharmaceutical Company Information
- 8.13.2 Chengyi Pharmaceutical Business Overview
- 8.13.3 Chengyi Pharmaceutical Glucosamine Sales, Value and Gross Margin (2021-2026)
- 8.13.4 Chengyi Pharmaceutical Glucosamine Product Portfolio
- 8.13.5 Chengyi Pharmaceutical Recent Developments
- 8.14 Nanjing Health Herb Bio-Tech
- 8.14.1 Nanjing Health Herb Bio-Tech Company Information
- 8.14.2 Nanjing Health Herb Bio-Tech Business Overview
- 8.14.3 Nanjing Health Herb Bio-Tech Glucosamine Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Nanjing Health Herb Bio-Tech Glucosamine Product Portfolio
- 8.14.5 Nanjing Health Herb Bio-Tech Recent Developments
- 8.15 Shinfuda Marine Biotechnology
- 8.15.1 Shinfuda Marine Biotechnology Company Information
- 8.15.2 Shinfuda Marine Biotechnology Business Overview
- 8.15.3 Shinfuda Marine Biotechnology Glucosamine Sales, Value and Gross Margin (2021-2026)
- 8.15.4 Shinfuda Marine Biotechnology Glucosamine Product Portfolio
- 8.15.5 Shinfuda Marine Biotechnology Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Glucosamine Value Chain Analysis
- 9.1.1 Glucosamine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Glucosamine Sales Mode & Process
- 9.2 Glucosamine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Glucosamine Distributors
- 9.2.3 Glucosamine Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst